BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer
In one of oncology's most closely watched experiments, an antibody-drug conjugate paired with an immune checkpoint inhibitor has produced unusually ...
In one of oncology's most closely watched experiments, an antibody-drug conjugate paired with an immune checkpoint inhibitor has produced unusually ...
Recent research conducted by a team of Princeton University bioengineers has shed light on the complex relationship between diet and ...
Breast cancer remains a significant global health challenge, impacting millions of women across different cultures and demographics. Recent findings from ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine